In last trading session, Staar Surgical Co (NASDAQ:STAA) saw 0.44 million shares changing hands with its beta currently measuring 0.66. Company’s recent per share price level of $18.03 trading at $0.15 or 0.84% at ring of the bell on the day assigns it a market valuation of $889.34M. That closing price of STAA’s stock is at a discount of -176.54% from its 52-week high price of $49.86 and is indicating a premium of 25.12% from its 52-week low price of $13.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.66 million shares which gives us an average trading volume of 1.16 million if we extend that period to 3-months.

For Staar Surgical Co (STAA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.71. Splitting up the data highlights that, out of 13 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.6 in the current quarter.

Staar Surgical Co (NASDAQ:STAA) trade information

Upright in the green during last session for gaining 0.84%, in the last five days STAA remained trading in the green while hitting it’s week-highest on Wednesday, 04/23/25 when the stock touched $18.03 price level, adding 0.61% to its value on the day. Staar Surgical Co’s shares saw a change of -25.77% in year-to-date performance and have moved 6.75% in past 5-day. Staar Surgical Co (NASDAQ:STAA) showed a performance of 2.62% in past 30-days. Number of shares sold short was 5.21 million shares which calculate 4.81 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 48 to the stock, which implies a rise of 62.44% to its current value. Analysts have been projecting 45.03 as a low price target for the stock while placing it at a high target of 85. It follows that stock’s current price would drop -149.75% in reaching the projected high whereas dropping to the targeted low would mean a loss of -149.75% for stock’s current value.

Staar Surgical Co (STAA) estimates and forecasts

This year revenue growth is estimated to fall -17.06% from the last financial year’s standing.

12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 40.3M for the same. And 12 analysts are in estimates of company making revenue of 40.99M in the next quarter. Company posted 77.36M and 99M of sales in current and next quarters respectively a year earlier.

In 2025, company’s earnings growth rate is likely to be around -530.12% while estimates for its earnings growth in next 5 years are of -8.00%.

Staar Surgical Co (NASDAQ:STAA)’s Major holders

Insiders are in possession of 0.55% of company’s total shares while institution are holding 110.30 percent of that, with stock having share float percentage of 110.91%. Investors also watch the number of corporate investors in a company very closely, which is 110.30% institutions for Staar Surgical Co that are currently holding shares of the company. BROADWOOD CAPITAL INC is the top institutional holder at STAA for having 10.77 million shares of worth $512.68 million. And as of 2024-06-30, it was holding 21.9196 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 7.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 15.2438 of outstanding shares, having a total worth of $356.54 million.

On the other hand, iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 3.05 shares of worth $54.91 million or 6.17% of the total outstanding shares. The later fund manager was in possession of 1.55 shares on Dec 31, 2024 , making its stake of worth around $27.91 million in the company or a holder of 3.14% of company’s stock.